BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27913223)

  • 41. [The extrahepatic manifestations in hepatitis C virus (HCV) infection].
    Kolarski V; Petrova D; Todorov A; Slavchev B
    Vutr Boles; 1999; 31(2-3):11-5. PubMed ID: 10847135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extrahepatic manifestations of viral hepatitis.
    Amarapurkar DN; Amarapurkar AD
    Ann Hepatol; 2002; 1(4):192-5. PubMed ID: 15280806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis E and diaphragmatic dysfunction: Case series and review of the literature.
    Westhoff M; Arias A; Litterst P
    Pneumologie; 2024 Jun; 78(6):400-408. PubMed ID: 38657646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy.
    Rianthavorn P; Thongmee C; Limpaphayom N; Komolmit P; Theamboonlers A; Poovorawan Y
    Scand J Infect Dis; 2010 May; 42(5):395-400. PubMed ID: 20100114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hepatitis E infections in rheumatology. A previously underestimated infectious disease?].
    Pischke S; Iking-Konert C
    Z Rheumatol; 2015 Oct; 74(8):731-6. PubMed ID: 26450437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.
    Goel A; Aggarwal R
    Expert Rev Gastroenterol Hepatol; 2016 Sep; 10(9):1065-74. PubMed ID: 27148907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuralgic Amyotrophy Associated With Hepatitis E Virus Infection: First Case in the United States.
    Avila JD; Lacomis D; Lam EM
    J Clin Neuromuscul Dis; 2016 Dec; 18(2):96-100. PubMed ID: 27861224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurologic complications of acute hepatitis E virus infection.
    Ripellino P; Pasi E; Melli G; Staedler C; Fraga M; Moradpour D; Sahli R; Aubert V; Martinetti G; Bihl F; Bernasconi E; Terziroli Beretta-Piccoli B; Cerny A; Dalton HR; Zehnder C; Mathis B; Zecca C; Disanto G; Kaelin-Lang A; Gobbi C
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31806684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis E Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person.
    Guinault D; Ribes D; Delas A; Milongo D; Abravanel F; Puissant-Lubrano B; Izopet J; Kamar N
    Am J Kidney Dis; 2016 Apr; 67(4):660-3. PubMed ID: 26682764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic hepatitis E: a review of the literature.
    Fujiwara S; Yokokawa Y; Morino K; Hayasaka K; Kawabata M; Shimizu T
    J Viral Hepat; 2014 Feb; 21(2):78-89. PubMed ID: 24383921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guillain-Barré and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan.
    Fukae J; Tsugawa J; Ouma S; Umezu T; Kusunoki S; Tsuboi Y
    Neurol Sci; 2016 Nov; 37(11):1849-1851. PubMed ID: 27389141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HEV infection in two referral centers in Spain: epidemiology and clinical outcomes.
    Lens S; Mensa L; Gambato M; González P; Torras X; Soriano G; Costa J; Capón A; Londoño MC; Mariño Z; Navasa M; Pérez-del-Pulgar S; Forns X
    J Clin Virol; 2015 Feb; 63():76-80. PubMed ID: 25600611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
    Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
    J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neurologic disorders and Hepatitis E: Review of literature].
    Belbézier A; Lagrange E; Bouillet L
    Rev Med Interne; 2018 Nov; 39(11):842-848. PubMed ID: 30033188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Extrahepatic manifestations in hepatitis C. Are they overlooked?].
    Kristiansen MG; Florholmen J
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):446-9. PubMed ID: 11255860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy.
    Ji SB; Lee SS; Jung HC; Kim HJ; Kim HJ; Kim TH; Jung WT; Lee OJ; Song DH
    Clin Mol Hepatol; 2016 Sep; 22(3):396-399. PubMed ID: 27572076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guillain-Barré syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review.
    Choudhary MC; Bajpai V; Anand L; Gupta E
    Intractable Rare Dis Res; 2019 Feb; 8(1):43-47. PubMed ID: 30881857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A case of Guillain-Barré syndrome following hepatitis E virus infection].
    Tarisawa M; Ando R; Eguchi K; Abe M; Matsushima M; Yabe I
    Rinsho Shinkeigaku; 2021 Dec; 61(12):869-873. PubMed ID: 34789632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiphasic presentation of neuralgic amyotrophy associated with hepatitis E virus infection.
    Arányi Z; Szpisjak L; Szőke K
    Muscle Nerve; 2020 Jan; 61(1):108-110. PubMed ID: 31573093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.